Table 1 Study characteristics
From: A scoping review on the conduct and reporting of scoping reviews
Study Characteristics (N = 516) | Count (%) | |
|---|---|---|
Year of Publication | ||
1999–2003 | 16 (3 %) | |
2004–2008 | 51 (10 %) | |
2009–2012 | 220 (43 %) | |
2013 | 127 (25 %) | |
2014 | 102 (20 %) | |
Continent | ||
North America | 275 (53 %) | |
Europe (including UK) | 196 (38 %) | |
Australia and New Zealand | 30 (6 %) | |
Asia | 9 (2 %) | |
Central and South America | 3 (1 %) | |
Africa | 1 (0 %) | |
Multiple continents | 2 (0 %) | |
Funding Sources | ||
Publicly sponsored | 330 (64 %) | |
Industry-sponsored | 11 (2 %) | |
Non-sponsored | 25 (5 %) | |
Funding not reported | 150 (29 %) | |
Duration of review | ||
<6 months | 23 (5 %) | |
6–12 months | 11 (2 %) | |
>12 months | 7 (1 %) | |
Not reported | 453 (92 %) | |
Review Size | ||
# of studies: mean (min to max) | 449: 117.7 (1 to 2600) |